26th Apr 2012 11:00
GW Pharmaceuticals plc
Notification of Results
Porton Down, UK, 26 April 2012: GW Pharmaceuticals plc (AIM: GWP) will be announcing its interim financial results for the six months ended 31 March 2012 on Tuesday 22 May 2012.
Enquiries:
FTI Consulting | 020 7831 3113 |
Ben Atwell / John Dineen |
Notes to Editors
About GW
GW was founded in 1998 and listed on the AIM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular multiple sclerosis and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. For further information, please visit www.gwpharm.com
Related Shares:
GWP.L